Paroxetine in the treatment of recurrent brief depressive disorder
Sathya Prakash1★, Piyali Mandal1, Rajesh Sagar1★ Corresponding author
- 1Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
CORRESPONDENCE
Sathya Prakash
Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
Volume 4, Issue 4 · pp. 288–290 · PUBLISHED 2013 · DOI: 10.4103/0976-500X.119718
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Recurrent brief depressive disorder is now a well‑recognized type of depressive disorder. However, there is still no clear evidence base for its treatment. The efficacy of several drugs including antidepressants and mood stabilizers in this disorder has been controversial. Methodological limitations need to be considered when interpreting the results of studies on efficacy of drugs in this disorder. We report a case of recurrent brief depressive disorder that responded dramatically to paroxetine. However, there is a need for larger, methodologically sound, double‑blind, placebo‑controlled studies.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Prakash, S., Mandal, P., & Sagar, R. (2013). Paroxetine in the treatment of recurrent brief depressive disorder. Journal of Pharmacology and Pharmacotherapeutics, 4(4), 288–290. https://doi.org/10.4103/0976-500X.119718
